Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07244445 · ClinicalTrials.gov registry record · NA
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
A NA study of Obesity & Overweight and Food Acceptance, sponsored by Ian J. Neeland, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT07244445: Recruiting NA study of Obesity & Overweight and Food Acceptance, sponsored by Ian J. Neeland, MD.
NCT07244445 is a NA study of Obesity & Overweight and Food Acceptance that is actively recruiting participants, run by Ian J. Neeland, MD. The registered enrollment target is 108 participants, roughly in line with the 111-participant average among 28 other Obesity & Overweight trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07244445, a NA study of Obesity & Overweight and Food Acceptance, is actively recruiting participants, sponsored by Ian J. Neeland, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study will look at how eating pistachios every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding pistachios to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating pistachios improves overall diet quality and health markers like tiredness and certain levels in blood.
Primary Outcome
Participants will rate their perceived hunger, fullness, and desire to eat on a 100-mm scale, with endpoints ranging from "not at all" to "extremely" for each category.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Pistachios
- PROCEDURE Dual-energy X-ray absorptiometry (DEXA) scans
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Clevland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2026-01-29 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07244445 shows while recruiting
NCT07244445 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 111-participant average among 28 other Obesity & Overweight trials with a reported enrollment target.
The record links to 3 conditions, with Obesity & Overweight appearing as the primary indexed condition, and to 2 interventions - of which Pistachios is the first listed.
NCT07244445 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07244445 about?
NCT07244445 is a clinical study titled "Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy". In this study will look at how eating pistachios every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding pistachios to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. ...
What is the current status of trial NCT07244445?
This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2026-01-29. Estimated completion is 2027-12.
What conditions does trial NCT07244445 study?
This clinical trial studies the following conditions: Obesity & Overweight, Food Acceptance, Dietary Change.
What interventions are being tested in trial NCT07244445?
The interventions under investigation include: Pistachios (DIETARY_SUPPLEMENT), Dual-energy X-ray absorptiometry (DEXA) scans (PROCEDURE).
Who is sponsoring clinical trial NCT07244445?
This trial is sponsored by Ian J. Neeland, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07244445 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07244445's enrollment target sits among peer trials
108 10th of 28 higher than 19 of 28 other Obesity & Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
RECRUITING · NA
-
FELLAShip to Better Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI